KAP Regarding Tuberculosis Among Physicians in Assiut City
Launched by ASSIUT UNIVERSITY · Apr 6, 2023
Trial Information
Current as of August 29, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial, titled "KAP Regarding Tuberculosis Among Physicians in Assiut City," aims to improve the understanding and awareness of tuberculosis (TB) among doctors in Assiut City. The goal is to strengthen education about TB as part of the national effort to control and manage this disease. While the trial is not yet recruiting participants, it will focus on non-specialist physicians working in primary health care units and hospitals in the area.
To be eligible for this study, participants must be doctors who do not specialize in a particular area of medicine. Unfortunately, specialist physicians will not be able to take part. If selected, participants can expect to engage in training and awareness activities that will help them better understand tuberculosis and its impact on public health. This knowledge is vital for improving patient care and managing TB effectively in the community.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Non specialist Physicians working and providing medical care in primary health care units and Hospitals in Assiut city.
- Exclusion Criteria:
- • specialist Physicians
About Assiut University
Assiut University, a prominent academic institution located in Egypt, is dedicated to advancing medical research and clinical trials that enhance healthcare outcomes. With a strong emphasis on innovation and collaboration, the university engages in a wide array of clinical studies across various disciplines, aiming to contribute valuable insights into disease prevention, diagnosis, and treatment. Assiut University's commitment to ethical research practices and rigorous scientific methodology ensures the integrity and reliability of its clinical trials, ultimately benefiting both the local community and the global medical landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials